Plus Therapeutics Stock Forecast

Sell candidate since Nov 17, 2025

The Plus Therapeutics, Inc. stock price fell by -7.08% on the last day (Monday, 17th Nov 2025) from $0.512 to $0.475. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 22.07% from a day low at $0.457 to a day high of $0.558. The price has been going up and down for this period, and there has been a -6.07% loss for the last 2 weeks. Volume has increased on the last day by 6 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 9 million shares were bought and sold for approximately $4.12 million.

Given the current short-term trend, the stock is expected to rise 15.18% during the next 3 months and, with a 90% probability hold a price between $0.547 and $1.09 at the end of this 3-month period.

PSTV Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Plus Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.534 and $0.617. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, October 06, 2025, and so far it has fallen -46.57%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Plus Therapeutics, Inc. stock

Plus Therapeutics, Inc. finds support from accumulated volume at $0.462 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.101 between high and low, or 22.07%. For the last week, the stock has had daily average volatility of 9.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PSTV) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Plus Therapeutics, Inc. to open at $0.497, and during the day (based on 14 day Average True Range), to move between $0.446 and $0.504, which gives a possible trading interval of +/-$0.0580 (+/-12.99%) up or down from last closing price. If Plus Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 12.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.478 (0.53%) than the support at $0.462 (2.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Plus Therapeutics, Inc. stock A Buy?

The Plus Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Plus Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.375 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.497 ( 4.54%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk